NSD1- A nd NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis

Suraj Peri, Evgeny Izumchenko, Adrian D. Schubert, Michael J. Slifker, Karen Ruth, Ilya G. Serebriiskii, Theresa Guo, Barbara A. Burtness, Ranee Mehra, Eric A. Ross, David Sidransky, Erica A. Golemis

Research output: Contribution to journalArticle

Abstract

Squamous cell carcinomas of the head and neck (SCCHN) affect anatomical sites including the oral cavity, nasal cavity, pharynx, and larynx. Laryngeal cancers are characterized by high recurrence and poor overall survival, and currently lack robust molecular prognostic biomarkers for treatment stratification. Using an algorithm for integrative clustering that simultaneously assesses gene expression, somatic mutation, copy number variation, and methylation, we for the first time identify laryngeal cancer subtypes with distinct prognostic outcomes, and differing from the non-prognostic laryngeal subclasses reported by The Cancer Genome Atlas (TCGA). Although most common laryngeal gene mutations are found in both subclasses, better prognosis is strongly associated with damaging mutations of the methyltransferases NSD1 and NSD2, with findings confirmed in an independent validation cohort consisting of 63 laryngeal cancer patients. Intriguingly, NSD1/2 mutations are not prognostic for nonlaryngeal SCCHN. These results provide an immediately useful clinical metric for patient stratification and prognostication.

Original languageEnglish (US)
Article number1772
JournalNature Communications
Volume8
Issue number1
DOIs
StatePublished - Dec 1 2017

Fingerprint

prognosis
mutations
set theory
Laryngeal Neoplasms
Tumors
tumors
Genes
cancer
Mutation
Methylation
Methyltransferases
Biomarkers
Gene expression
Neoplasms
stratification
Atlases
Nasal Cavity
pharynx
Larynx
Pharynx

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

Peri, S., Izumchenko, E., Schubert, A. D., Slifker, M. J., Ruth, K., Serebriiskii, I. G., ... Golemis, E. A. (2017). NSD1- A nd NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis. Nature Communications, 8(1), [1772]. https://doi.org/10.1038/s41467-017-01877-7

NSD1- A nd NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis. / Peri, Suraj; Izumchenko, Evgeny; Schubert, Adrian D.; Slifker, Michael J.; Ruth, Karen; Serebriiskii, Ilya G.; Guo, Theresa; Burtness, Barbara A.; Mehra, Ranee; Ross, Eric A.; Sidransky, David; Golemis, Erica A.

In: Nature Communications, Vol. 8, No. 1, 1772, 01.12.2017.

Research output: Contribution to journalArticle

Peri, S, Izumchenko, E, Schubert, AD, Slifker, MJ, Ruth, K, Serebriiskii, IG, Guo, T, Burtness, BA, Mehra, R, Ross, EA, Sidransky, D & Golemis, EA 2017, 'NSD1- A nd NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis', Nature Communications, vol. 8, no. 1, 1772. https://doi.org/10.1038/s41467-017-01877-7
Peri, Suraj ; Izumchenko, Evgeny ; Schubert, Adrian D. ; Slifker, Michael J. ; Ruth, Karen ; Serebriiskii, Ilya G. ; Guo, Theresa ; Burtness, Barbara A. ; Mehra, Ranee ; Ross, Eric A. ; Sidransky, David ; Golemis, Erica A. / NSD1- A nd NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis. In: Nature Communications. 2017 ; Vol. 8, No. 1.
@article{70697f9e340746c5a8ddc6ad07c128f6,
title = "NSD1- A nd NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis",
abstract = "Squamous cell carcinomas of the head and neck (SCCHN) affect anatomical sites including the oral cavity, nasal cavity, pharynx, and larynx. Laryngeal cancers are characterized by high recurrence and poor overall survival, and currently lack robust molecular prognostic biomarkers for treatment stratification. Using an algorithm for integrative clustering that simultaneously assesses gene expression, somatic mutation, copy number variation, and methylation, we for the first time identify laryngeal cancer subtypes with distinct prognostic outcomes, and differing from the non-prognostic laryngeal subclasses reported by The Cancer Genome Atlas (TCGA). Although most common laryngeal gene mutations are found in both subclasses, better prognosis is strongly associated with damaging mutations of the methyltransferases NSD1 and NSD2, with findings confirmed in an independent validation cohort consisting of 63 laryngeal cancer patients. Intriguingly, NSD1/2 mutations are not prognostic for nonlaryngeal SCCHN. These results provide an immediately useful clinical metric for patient stratification and prognostication.",
author = "Suraj Peri and Evgeny Izumchenko and Schubert, {Adrian D.} and Slifker, {Michael J.} and Karen Ruth and Serebriiskii, {Ilya G.} and Theresa Guo and Burtness, {Barbara A.} and Ranee Mehra and Ross, {Eric A.} and David Sidransky and Golemis, {Erica A.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41467-017-01877-7",
language = "English (US)",
volume = "8",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - NSD1- A nd NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis

AU - Peri, Suraj

AU - Izumchenko, Evgeny

AU - Schubert, Adrian D.

AU - Slifker, Michael J.

AU - Ruth, Karen

AU - Serebriiskii, Ilya G.

AU - Guo, Theresa

AU - Burtness, Barbara A.

AU - Mehra, Ranee

AU - Ross, Eric A.

AU - Sidransky, David

AU - Golemis, Erica A.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Squamous cell carcinomas of the head and neck (SCCHN) affect anatomical sites including the oral cavity, nasal cavity, pharynx, and larynx. Laryngeal cancers are characterized by high recurrence and poor overall survival, and currently lack robust molecular prognostic biomarkers for treatment stratification. Using an algorithm for integrative clustering that simultaneously assesses gene expression, somatic mutation, copy number variation, and methylation, we for the first time identify laryngeal cancer subtypes with distinct prognostic outcomes, and differing from the non-prognostic laryngeal subclasses reported by The Cancer Genome Atlas (TCGA). Although most common laryngeal gene mutations are found in both subclasses, better prognosis is strongly associated with damaging mutations of the methyltransferases NSD1 and NSD2, with findings confirmed in an independent validation cohort consisting of 63 laryngeal cancer patients. Intriguingly, NSD1/2 mutations are not prognostic for nonlaryngeal SCCHN. These results provide an immediately useful clinical metric for patient stratification and prognostication.

AB - Squamous cell carcinomas of the head and neck (SCCHN) affect anatomical sites including the oral cavity, nasal cavity, pharynx, and larynx. Laryngeal cancers are characterized by high recurrence and poor overall survival, and currently lack robust molecular prognostic biomarkers for treatment stratification. Using an algorithm for integrative clustering that simultaneously assesses gene expression, somatic mutation, copy number variation, and methylation, we for the first time identify laryngeal cancer subtypes with distinct prognostic outcomes, and differing from the non-prognostic laryngeal subclasses reported by The Cancer Genome Atlas (TCGA). Although most common laryngeal gene mutations are found in both subclasses, better prognosis is strongly associated with damaging mutations of the methyltransferases NSD1 and NSD2, with findings confirmed in an independent validation cohort consisting of 63 laryngeal cancer patients. Intriguingly, NSD1/2 mutations are not prognostic for nonlaryngeal SCCHN. These results provide an immediately useful clinical metric for patient stratification and prognostication.

UR - http://www.scopus.com/inward/record.url?scp=85034955204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034955204&partnerID=8YFLogxK

U2 - 10.1038/s41467-017-01877-7

DO - 10.1038/s41467-017-01877-7

M3 - Article

C2 - 29176703

AN - SCOPUS:85034955204

VL - 8

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

IS - 1

M1 - 1772

ER -